Ilka Schellschmidt

686 total citations
13 papers, 496 citations indexed

About

Ilka Schellschmidt is a scholar working on Public Health, Environmental and Occupational Health, Reproductive Medicine and Dermatology. According to data from OpenAlex, Ilka Schellschmidt has authored 13 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 5 papers in Reproductive Medicine and 2 papers in Dermatology. Recurrent topics in Ilka Schellschmidt's work include Reproductive Health and Contraception (8 papers), Ovarian function and disorders (3 papers) and Pregnancy and Medication Impact (3 papers). Ilka Schellschmidt is often cited by papers focused on Reproductive Health and Contraception (8 papers), Ovarian function and disorders (3 papers) and Pregnancy and Medication Impact (3 papers). Ilka Schellschmidt collaborates with scholars based in Germany, United States and United Kingdom. Ilka Schellschmidt's co-authors include Kristina Gemzell‐Danielsson, Dan Apter, H Gollnick, Maureen Cronin, Jürgen Dinger, Axel Kamischke, Sigrid von Eckardstein, Eberhard Nieschlag, Ulrike Schumacher and Carolyn Westhoff and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, American Journal of Obstetrics and Gynecology and Fertility and Sterility.

In The Last Decade

Ilka Schellschmidt

13 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilka Schellschmidt Germany 9 328 180 114 101 83 13 496
Anaglória Pontes Brazil 16 309 0.9× 456 2.5× 143 1.3× 101 1.0× 162 2.0× 46 712
Sezai Şahmay Türkiye 14 462 1.4× 571 3.2× 104 0.9× 102 1.0× 43 0.5× 36 647
Richard V. Grazi United States 12 349 1.1× 460 2.6× 157 1.4× 57 0.6× 42 0.5× 42 639
Hee Jun Lee South Korea 12 172 0.5× 182 1.0× 90 0.8× 25 0.2× 23 0.3× 22 328
Gabriela Noé Chile 9 268 0.8× 151 0.8× 95 0.8× 210 2.1× 44 0.5× 13 446
V. Abdelmassih Brazil 11 255 0.8× 420 2.3× 118 1.0× 29 0.3× 221 2.7× 24 562
M. Rocca Italy 13 218 0.7× 370 2.1× 72 0.6× 32 0.3× 201 2.4× 20 515
Sandra Dieben Netherlands 9 284 0.9× 558 3.1× 150 1.3× 74 0.7× 234 2.8× 13 724
Dietmar Trummer Germany 9 260 0.8× 145 0.8× 59 0.5× 23 0.2× 65 0.8× 14 318
Samira Golezar Iran 7 131 0.4× 121 0.7× 25 0.2× 73 0.7× 5 0.1× 13 334

Countries citing papers authored by Ilka Schellschmidt

Since Specialization
Citations

This map shows the geographic impact of Ilka Schellschmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilka Schellschmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilka Schellschmidt more than expected).

Fields of papers citing papers by Ilka Schellschmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilka Schellschmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilka Schellschmidt. The network helps show where Ilka Schellschmidt may publish in the future.

Co-authorship network of co-authors of Ilka Schellschmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Ilka Schellschmidt. A scholar is included among the top collaborators of Ilka Schellschmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilka Schellschmidt. Ilka Schellschmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gerlinger, Christoph, James Trussell, Uwe Mellinger, et al.. (2014). Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population. Contraception. 90(2). 142–146. 14 indexed citations
2.
Clerson, Pierre, Olivier Graesslin, Adam Gater, et al.. (2014). EVAPIL-R Scale: Continuous Development and Validation of a Tool to Assess Patient-Reported Tolerability of Different Contraceptive Methods in Longitudinal Studies. Clinical Therapeutics. 36(5). 638–647.e3. 4 indexed citations
4.
Gemzell‐Danielsson, Kristina, Ilka Schellschmidt, & Dan Apter. (2012). A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena. Fertility and Sterility. 97(3). 616–622.e3. 134 indexed citations
5.
Gerlinger, Christoph, Harald Siedentop, Oke Gerke, Ilka Schellschmidt, & Jan Endrikat. (2011). Optimal dose de-escalation trial designs for novel contraceptives in women. Computational Statistics & Data Analysis. 56(5). 1061–1068. 1 indexed citations
6.
Cronin, Maureen, Ilka Schellschmidt, & Jürgen Dinger. (2009). Rate of Pregnancy After Using Drospirenone and Other Progestin-Containing Oral Contraceptives. Obstetrics and Gynecology. 114(3). 616–622. 32 indexed citations
7.
Dinger, Jürgen, Maureen Cronin, Sabine Möhner, et al.. (2009). Oral contraceptive effectiveness according to body mass index, weight, age, and other factors. American Journal of Obstetrics and Gynecology. 201(3). 263.e1–263.e9. 51 indexed citations
8.
9.
Foidart, Jean‐Michel, et al.. (2005). The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days. Contraception. 73(1). 34–40. 31 indexed citations
10.
Croxatto, H.B., et al.. (2005). New Mechanisms for Tissue-Selective Estrogen-Free Contraception. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 4 indexed citations
11.
Gollnick, H, et al.. (2004). Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment.. PubMed. 74(2). 123–30. 71 indexed citations
12.
Kamischke, Axel, et al.. (2002). An Effective Hormonal Male Contraceptive Using Testosterone Undecanoate with Oral or Injectable Norethisterone Preparations. The Journal of Clinical Endocrinology & Metabolism. 87(2). 530–539. 96 indexed citations
13.
Reles, Angela, Conway Gee, Ilka Schellschmidt, et al.. (1998). Prognostic Significance of DNA Content and S-Phase Fraction in Epithelial Ovarian Carcinomas Analyzed by Image Cytometry. Gynecologic Oncology. 71(1). 3–13. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026